Literature DB >> 21226594

Rapid molecular detection of tuberculosis.

Andrea Zbinden, Peter M Keller, Guido V Bloemberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21226594     DOI： 10.1056/NEJMc1011919

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Diagnostic implications of inconsistent results obtained with the Xpert MTB/Rif assay in detection of Mycobacterium tuberculosis isolates with an rpoB mutation associated with low-level rifampin resistance.

Authors:  Akos Somoskovi; Vanessa Deggim; Diana Ciardo; Guido V Bloemberg
Journal:  J Clin Microbiol       Date:  2013-07-12       Impact factor: 5.948

2.  Evaluation of the AID TB resistance line probe assay for rapid detection of genetic alterations associated with drug resistance in Mycobacterium tuberculosis strains.

Authors:  C Ritter; K Lucke; F A Sirgel; R W Warren; P D van Helden; E C Böttger; G V Bloemberg
Journal:  J Clin Microbiol       Date:  2014-01-08       Impact factor: 5.948

3.  Rapid implementation of new TB diagnostic tests: is it too soon for a global roll-out of Xpert MTB/RIF?

Authors:  Daniela E Kirwan; María Kathia Cárdenas; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

4.  Integrating the Xpert MTB/RIF assay into a diagnostic workflow for rapid detection of Mycobacterium tuberculosis in a low-prevalence area.

Authors:  Vanessa Deggim; Akos Somoskovi; Antje Voit; Erik C Böttger; Guido V Bloemberg
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

5.  Reply to "performance of the Xpert MTB/RIF assay on nonrespiratory specimens and accuracy of this assay for detection of rifampin resistance in a low-prevalence setting".

Authors:  Vanessa Deggim; Akos Somoskovi; Guido Bloemberg
Journal:  J Clin Microbiol       Date:  2014-02       Impact factor: 5.948

Review 6.  Reporter phage and breath tests: emerging phenotypic assays for diagnosing active tuberculosis, antibiotic resistance, and treatment efficacy.

Authors:  Paras Jain; David S Thaler; Mamoudou Maiga; Graham S Timmins; William R Bishai; Graham F Hatfull; Michelle H Larsen; William R Jacobs
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.